Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Non Operating Income (2016 - 2025)

Medifast's Non Operating Income history spans 16 years, with the latest figure at $5.5 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 24.9% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $12.7 million, up 265.76%, while the annual FY2025 figure was $8.6 million, 843.23% up from the prior year.
  • Non Operating Income reached $5.5 million in Q4 2025 per MED's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $5.5 million in Q4 2025 to a low of -$4.1 million in Q2 2024.
  • Average Non Operating Income over 5 years is $796550.0, with a median of -$9000.0 recorded in 2022.
  • The largest YoY upside for Non Operating Income was 364600.0% in 2024 against a maximum downside of 7880.39% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$86000.0 in 2021, then tumbled by 725.58% to -$710000.0 in 2022, then skyrocketed by 92.96% to -$50000.0 in 2023, then soared by 8934.0% to $4.4 million in 2024, then rose by 24.9% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Non Operating Income are $5.5 million (Q4 2025), $1.4 million (Q3 2025), and $3.9 million (Q2 2025).